Rockwell Medical, Inc.
Rockwell Medical, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 1996, the company has established itself as a leader in developing innovative therapies for patients with chronic kidney disease and end-stage renal disease. With a focus on dialysis and iron replacement therapies, Rockwell Medical offers unique products such as Triferic, which is designed to maintain iron levels in patients undergoing dialysis. The company operates primarily in North America, with a growing presence in international markets. Rockwell Medical's commitment to research and development has led to significant milestones, including FDA approvals and partnerships that enhance its market position. Recognised for its dedication to improving patient outcomes, Rockwell Medical continues to advance the field of renal care through its specialised offerings and innovative solutions.
DitchCarbon Score
How does Rockwell Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Rockwell Medical, Inc.'s score of 23 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Rockwell Medical, Inc.'s reported carbon emissions
Rockwell Medical, Inc., headquartered in the US, has set ambitious climate commitments aimed at achieving carbon neutrality for Scope 1 and Scope 2 emissions by 2030. Although specific emissions data for the most recent year is not available, the company is actively working towards its net-zero goal, which reflects a significant commitment to reducing its carbon footprint. The initiatives focus on both direct emissions (Scope 1) and indirect emissions from purchased energy (Scope 2). By targeting these scopes, Rockwell Medical aims to enhance its sustainability practices and contribute positively to the environment. The commitment to carbon neutrality by 2030 positions the company as a proactive player in the healthcare sector's response to climate change, aligning with industry standards for environmental responsibility. As of now, there are no specific reduction percentages disclosed, but the overarching goal underscores Rockwell Medical's dedication to addressing climate change and reducing its overall environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Rockwell Medical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
